(Switzerland) Altimmune (US) Glenmark Pharmaceuticals Ltd (India) Biocon (India) Teva Pharmaceuticals (Israel) MARKET SCOPE WHAT IS IN IT FOR YOU: GLP-1 Agonists Market REPORT CONTENT GUIDE DELIVERED CUSTOMIZATIONS We have successfully delivered the following deep-dive customizations: RECENT DEVELOPMENTS September 2025 : Novo Nordisk (Denmark) received EU approval for its oral GLP-1 receptor agonist drug, Rybelsus, to reduce cardiovascular death, heart attack, and stroke
Avoid fried, fatty, and spicy foods that can make nausea and stomach discomfort worse
By keeping a close eye on patients and adjusting dosages, we aim for the best results and safety
Significant reductions in subcutaneous fat can alter skin tension, hydration, and barrier function, which may manifest as dryness, sensitivity, or a sensation of tightness
Muscle recovery
A two-month trial in 103 healthy postmenopausal women found a significant difference in glucose and insulin levels between a group that took up to 800 mg EGCG per day and a placebo group